Codexis Spreading the Promise of Engineered Proteins at SynBioBeta Summit
“The optionality to design a new protein molecule is effectively infinite,” said
Successful Partnering in the Bioeconomy
October 2, 10:10-10:40 a.m.
Nicols and Tate & Lyle CTO
Michael Harrisonwill discuss their companies’ partnership and how vital successful partnering is to the industry.
Commercial Success of CodeEvolver®
October 2, 12:30–1:15 p.m.
Dipnath Baidyaroy, Ph.D., senior director of strategic alliances and business operations and
Jonathan Vroom, Ph.D., principal scientist, explain how Codexishas used its unique CodeEvolver® protein engineering technology to rapidly gain success in commercial markets.
Wide Applications of Protein Engineering
October 3, 2:30–3:15 p.m.
- Gjalt Huisman, Ph.D., senior vice president of strategic development, will moderate.
Matt Miller, Ph.D., senior scientist, will present: RNA polymerase for capped messenger RNA manufacturing & DNA polymerase for next-gen sequencing.
Kerryn McCluskie, Ph.D., senior director of translational biology, will present: Orally administrable biotherapeutics.
Oscar Alvizo, Ph.D., director of computational biology, will present: AI/machine learning in protein engineering.
Attendees are also invited to visit
To the extent that statements contained in this press release are not descriptions of historical facts regarding
LHA Investor Relations
Jody Cain, 310-691-7100